Business
Pete Pharma and Fagron Enter Strategic Distribution Partnership to Expand Access to Pharmaceutical 3D Printing Across North America
PHOENIX, April 16, 2026--Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D pharmaceutical printing, delivery systems, and scalable manufacturing platforms, today announced a strategic distribution and commercialization partnership with Fagron, Inc., a global leader in pharmaceutical compounding and personalized medicine.
About this update from Fagron Sa
[{"type":"image","alt":"Amy Jones - Business Leader, Brands & Essentials at Fagron North America / Marc Joiner - Co Founder of Pete Pharma / Andrew Allan - Vice President, Sales at Fagron North America","displaySize":"","headline":null,"caption":"Amy Jones - Business Leader, Brands & Essentials at Fagron North America / Marc Joiner - Co Founder of Pete Pharma / Andrew Allan - Vice President, Sales at Fagron North America","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":325,"url":"https://media.zenfs.com/en/business-wire.com/f2d1df4901e7f9509a8ff158721f93b4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YJKx9ycFPeAjn2mCuTHNWw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY1MA--/https://media.zenfs.com/en/business-wire.com/f2d1df4901e7f9509a8ff158721f93b4","width":480,"height":325}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":237,"url":"https://media.zenfs.com/en/business-wire.com/593021f28b5b24457f553b16c89c0ef4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/76Fdd6TvIkjxRLUZ6_rGeQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ3NA--/https://media.zenfs.com/en/business-wire.com/593021f28b5b24457f553b16c89c0ef4","width":480,"height":237}}},{"type":"text","content":"PHOENIX, April 16, 2026--(BUSINESS WIRE)--Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D pharmaceutical printing, delivery systems, and scalable manufacturing platforms, today announced a strategic distribution and commercialization partnership with Fagron, Inc., a global leader in pharmaceutical compounding and personalized medicine.","length":413,"tagName":"p"},{"type":"text","content":"Under the terms of the agreement, Fagron has been appointed as an exclusive reseller of Pete Pharma’s 3D printing platform across the United States and Canada. The partnership will focus on expanding access to automated solid dosage form manufacturing for both 503A and 503B compounding pharmacies.","length":298,"tagName":"p"},{"type":"text","content":"The collaboration brings together the FABRx and Pete Pharma 3D pharmaceutical printing platform, including the M3DIMAKER hardware, software infrastructure, and delivery systems, with Fagron’s extensive comm...